2024年狂妄症管理:2016年以来临床实践的现状检查和演变
Oliver Coolens1, Arnold Kaltwasser1, Tobias Melms2
1Nursing Education Department, Academy of the District Hospitals Reutlingen, Germany.
Intensive & critical care nursing
|March 9, 2025
概括
质量改进项目在德语国家加强了重症监护室 (ICU) 的妄想管理. 尽管存在时间限制等持续障碍,但自2016年以来,验证评估和预防计划等关键实践得到了显著改善.
科学领域:
- 关键护理医学 关键护理医学
- 老年学是一门学科.
- 神经科学是一个神经科学.
背景情况:
- 在重症监护室 (ICU) 的 Delirium 与不良结果有关,包括长时间住院,认知障碍和死亡率增加.
- 在ICU中实施有效的妄想管理策略对医疗保健专业人员提出了重大挑战.
- 2016年至2024年间,德语国家已经采取了众多质量改善举措,以应对痴呆症.
研究的目的:
- 评估2024年德语国家ICU中痴呆症管理的现状.
- 自2016年以来,确定和量化妄的预防,检测和治疗方面的变化.
- 评估质量改进项目的对妄症护理实践的影响.
主要方法:
- 进行了一项比较调查研究,复制了2016年在德语国家ICU中在2024年进行的一项调查.
- 该调查收集了有关医院和ICU特征, Delirium 管理结构,流程,评估程序的数据,并确定了障碍.
- 数据使用雪球采样方法进行统计分析,用于调查分布.
主要成果:
- 经过验证的妄想评估工具的使用率从2016年的56.8%增加到2024年的74.4%.
- 在预防计划 (34.6%至44.7%) 和患者/家庭信息材料 (18.9%至33.8%) 中观察到显著改善.
- 相反,痴呆症查减少 (23.7%至14.8%),限制措施的使用减少 (68.3%至58.4%). 主要障碍仍然是"缺乏时间和人员".
结论:
- 2016年至2024年间,在德语系ICU中, Delirium管理实践发生了显著的文化转变.
- 质量改进项目似乎提高了妄想意识,并有助于持续的护理文化变革.
- 解决特定障碍和提高妄想意识对于改善和保持ICU有效管理至关重要.
相关概念视频
Psychosis: Goals of Pharmacotherapy
101
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
101
Drug Therapy
34
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
34
Acute Pancreatitis II: Clinical Manifestations and Management
78
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
78
Management of Insomnia
229
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
229
Alzheimer's Disease: Treatment
142
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
142
Alzheimer's Disease: Overview
412
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
412


